Tracking system for studies should be in place

BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7458.173-b (Published 15 July 2004) Cite this as: BMJ 2004;329:173
  1. J A C Delaney (chris.delaney@clinepi.mcgill.ca), statistician, clinical epidemiology
  1. Royal Victoria Hospital, R 4.36, 687 Pine Avenue W, Montreal, QC, Canada H3A 1A1

    EDITOR—GlaxoSmithKline's recent legal troubles resulting from not publishing negative results of clinical trials on the antidepressant paroxetine are just part of a larger problem of publication bias in modern research.1

    There has been …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription